Evidence map›Paper›PMID 24962386›Full record

ArticleMolecules (Basel, Switzerland)2014

Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway.

Wan-Rong Huang, Yue Zhang, Xin Tang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wan-Rong HuangTianjin Eye Hospital, Clinic College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China. scarlethwang@aliyun.com.
Yue ZhangTianjin Eye Hospital, Clinic College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China. zmoon0225@126.com.
Xin TangTianjin Eye Hospital, Clinic College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China. tangprofessorx@163.com.
Tianjin Medical University Eye Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shikonin is a compound from the herbal plant Lithospermum erythrorhizon that has been proved to possess powerful anti-proliferative effect on many kinds of cancers and to be safe in in vivo study. Posterior capsular opacification (PCO), the most frequent complication of cataract surgery, is mainly caused by the uncontrolled proliferation of retained human lens epithelial cells (HLEs). In this study, we investigated the effect of shikonin on the proliferation of HLEs and explored its underlying mechanism of action. Shikonin significantly inhibited the proliferation of HLEs in a dose- and time-dependent manner. Its anti-proliferative effect was exerted through induction of apoptosis. Reactive oxygen species (ROS) generation played an essential role in this apoptotic process. Interestingly, scavenging of ROS completely blocked the apoptosis induced by shikonin. In addition, the treatment of shikonin in HLEs significantly increased the ratio of Bax/Bcl-2, disrupted mitochondria membrane potential (MMP) and activated caspases. The inhibition of caspase largely blocks the apoptosis. The changes of MAPK pathway were also demonstrated. Shikonin effectively inhibited the phosphorylation of ERK, while it activated the phosphorylation of JNK and p38. These results suggested that shikonin inhibited the proliferation of HLEs by inducing apoptosis through ROS generation and the caspase-dependent pathway and the MAPK pathway was also involved.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalApoptosisbcl-2-Associated X ProteinCaspase 3Caspase 7Caspase 9Caspase InhibitorsCell LineCell ProliferationDrugs, Chinese HerbalEpithelial CellsExtracellular Signal-Regulated MAP KinasesHumansJNK Mitogen-Activated Protein KinasesLens, CrystallineMembrane Potential, MitochondrialAnti-Inflammatory Agents, Non-Steroidalbcl-2-Associated X ProteinCaspase 3Caspase 7Caspase 9Caspase InhibitorsDrugs, Chinese HerbalExtracellular Signal-Regulated MAP KinasesJNK Mitogen-Activated Protein KinasesNaphthoquinonesp38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-bcl-2Reactive Oxygen Speciesshikonin

Identifiers

PMID24962386
PMCPMC6270879
OpenAlexW1983176022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.